| Weight | 267.278 g/mol |
|---|---|
| Formula | C10H21NO7 |
| Hydrogen Acceptors | 8 |
| Hydrogen Donors | 8 |
| Aromatic Rings | 0 |
| Rotatable Bonds | 5 |
voglibose (83480-29-9)
"What do you need help with?"
LabBot
- Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance (The Lancet, 2009)
- Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients. (Journal of Diabetes and Its Complications, 2000)
- Effect of two -glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms (Metabolism-clinical and Experimental, 2005)
- Voglibose (AO-128) Is an Efficient -Glucosidase Inhibitor and Mobilizes the Endogenous GLP-1 Reserve (Digestion, 1995)
- Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, doubleblind trial (Diabetes, Obesity and Metabolism, 2010)
- Voglibose (Basen, AO-128), One of the Most Important -Glucosidase Inhibitors (Current Medicinal Chemistry, 2006)
-
Predict GHS Hazards for Any Chemical in silico.
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. -
SMILESC1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO
-
InChIKeyFZNCGRZWXLXZSZ-UHFFFAOYSA-N
- Pubchem - voglibose
- Wikipedia - voglibose
Voglibose (INN and USAN, trade name Voglib, marketed by Mascot Health Series) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. Voglibose delays the absorption of glucose thereby reducing the risk of macrovascular complications. Voglibose is a research product of Takeda Pharmaceutical Company, Japan's largest pharmaceutical company.
Suppliers
Most-cited Publications
Areas of Application
Safety
Alternate Names
External Links
Synthesis
Similar Compounds
D-manno-Heptulose
(29325-35-7, 3019-74-7, 3615-44-9)
1 alternate name
3 suppliers
shikimic acid
(138-59-0)
1 alternate name
3 suppliers
endothall
(28874-46-6, 145-73-3)
1 alternate name
5 safety hazards
3 suppliers
UNII-18F7018HG1
(28871-63-8)
1 alternate name
3 suppliers
D-(+)-Glucosamine hydrochloride
(3416-24-8)
1 alternate name
3 suppliers
Gallic acid
(149-91-7)
1 alternate name
3 suppliers
(3R,4S,5R)--3,4,5-trihydroxycyclohex-1-ene-1-carboxylate
(138-59-0)
1 alternate name
3 suppliers
Texanol
(77-68-9, 25265-77-4)
1 alternate name
3 suppliers
1,6-Anhydro-beta-D-glucopyranose
(498-07-7)
1 alternate name
3 suppliers
D-Isoglucosamine
(4429-04-3)
1 alternate name
3 suppliers
Leucoglucosan
(498-07-7)
1 alternate name
3 suppliers
inositol 1-phosphate
(15421-51-9, 2831-74-5, 573-35-3)
1 alternate name
3 suppliers
N-Methyl-D-glucamine
(6284-40-8)
1 alternate name
3 suppliers
d-iduronic acid
(3402-98-0)
1 alternate name
3 suppliers
meglumine
(6284-40-8)
1 alternate name
3 suppliers
Ins6P
(15421-51-9, 21667-10-7, 46495-39-0)
1 alternate name
3 suppliers
Inositol 3-phosphate
(2831-74-5, 573-35-3)
1 alternate name
3 suppliers
cis-Aconitic acid
(585-84-2, 499-12-7)
1 alternate name
3 suppliers
Menthyl acetate
(89-48-5, 20777-36-0, 29066-34-0, 16409-45-3, 2552-91-2, 2230-87-7, 2623-23-6)
1 alternate name
3 suppliers
1,5-Anhydro-D-glucitol
(154-58-5)
1 alternate name
3 suppliers
trans-Aconitic acid
(499-12-7, 4023-65-8)
1 alternate name
3 suppliers
1,4-CYCLOHEXANEDICARBOXYLIC ACID
(619-82-9, 619-81-8, 1076-97-7)
1 alternate name
3 suppliers
3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone
(77439-76-0)
1 alternate name
2 safety hazards
3 suppliers
134-03-2
(134-03-2)
1 alternate name
3 suppliers
122551-89-7
(122551-89-7)
1 alternate name
3 suppliers
voglibose
CAS Directory
